Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study

Efstathios Kastritis; Ageliki Laina; Georgios Georgiopoulos; Maria Gavriatopoulou; Eleni‐Dimitra Papanagnou; Evangelos Eleutherakis‐Papaiakovou; Despina Fotiou; Nikolaos Kanellias; Ioanna Dialoupi; Nikolaos Makris; Efstathios Manios; Magdalini Migkou; Μαρία Ρούσσου; Maria Kotsopoulou; Konstantinos Stellos; Evangelos Terpos; Ioannis P. Trougakos; Κimon Stamatelopoulos; Meletios A Dimopoulos

doi:10.1038/s41375-021-01141-4

Related publications

Article2018

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Efstathios Kastritis, Ageliki Laina, Maria Gavriatopoulou, Georgios Georgiopoulos, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, Nikolaos Kanellias, Ioanna Dialoupi, Nikolaos Makris, Efstathios Manios, Magdalini Migkou, Dimitrios C. Ziogas, Μαρία Ρούσσου, Αριστέα-Μαρία Παπανώτα, Eleni‐Dimitra Papanagnou, Evangelos Terpos, Ioannis P. Trougakos, Κimon Stamatelopoulos, Meletios A Dimopoulos

Article2021

Global deterioration of cardiovascular mechanics by carfilzomib treatment is associated with proteasome activity in patients with relapsed multiple myeloma

Nikolaos Makris, Ageliki Laina, Georgios Georgiopoulos, Maria Gavriatopoulou, Eleni‐Dimitra Papanagnou, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, Ioanna Dialoupi, Magdalini Migkou, Μαρία Ρούσσου, Evangelos Terpos, Ioannis P. Trougakos, Meletios A Dimopoulos, Efstathios Kastritis, K. Stamatelopoulos

Article2021

Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study

Evangelos Terpos, Κimon Stamatelopoulos, Nikolaos Makris, Georgios Georgiopoulos, Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Ageliki Laina, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, Nikolaos Kanellias, Panagiotis Malandrakis, D Delialis, Ioanna Andreadou, Efstathios Kastritis, Meletios A Dimopoulos

Letter2013

Cardiovascular Biomarkers, Cardiac Dysfunction, and Outcomes in Patients With Type 2 Diabetes: A Prospective, Multicenter Study

Serge Masson, Roberto Latini, Giovanni Cioffi, Renato Urso, Tarcisio Vago, Donata Lucci, Gian Francesco Mureddu, Luigi Tarantini, Pompilio Faggiano, Daniela Girfoglio, Mario Velussi, Aldo Maggioni, Carlo Giorda, Marco Comaschi

Article2017

Comparison of Proteasome Inhibitors-Induced Cardiotoxicity (carfilzomib vs. bortezomib): Insights into the Molecular Mechanisms

Georgios Kremastiotis, Panagiotis Efentakis, Aimilia Varela, Constantinos H. Davos, Eleni‐Dimitra Papanagnou, Ioannis P. Trougakos, Eftathios Kastritis, Evangelia Chavdoula, Efstathios K. Iliodromitis, Apostolos Klinakis, Meletios A Dimopoulos, Ioanna Andreadou, Evangelos Terpos